According to REGENXBIO's latest financial reports the company has A$0.42 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $A$0.41 B | -8.77% |
2023-12-31 | $A$0.45 B | -39.68% |
2022-12-31 | $A$0.75 B | -28.05% |
2021-12-31 | $A$1.05 B | 114.59% |
2020-12-31 | $A$0.49 B | -23.6% |
2019-12-31 | $A$0.64 B | -10.98% |
2018-12-31 | $A$0.72 B | 208.1% |
2017-12-31 | $A$0.23 B | 4.49% |
2016-12-31 | $A$0.22 B | -24.61% |
2015-12-31 | $A$0.29 B | -4374.57% |
2014-12-31 | $-A$6.97 Million | 189.8% |
2013-12-31 | $-A$2.41 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | A$0.33 B | -19.86% | ๐บ๐ธ USA |